The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults [PDF]
, 2015 Dolly A. Parasramupria +4 more
core +1 more source
Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism
Therapeutics and Clinical Risk Management, 2016 Katie B Tellor, Joseph S Van Tuyl, Anastasia L Armbruster Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, MO, USA Abstract: Edoxaban, a factor Xa inhibitor, was approved by the United States Food and Drug Administration in
Tellor KB, Van Tuyl JS, Armbruster AL
doaj
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal [PDF]
, 2016 core +1 more source
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment [PDF]
, 2016 core +1 more source
Edoxaban for prevention of venous thromboembolism after major orthopedic surgery
Orthopedic Research and Reviews, 2012 Hiroyuki Kawaji,1 Masaji Ishii,1 Yasunobu Tamaki,1 Kan Sasaki,2 Michiaki Takagi,21Department of Orthopaedic Surgery, Saiseikai Yamagata Saisei Hospital, 2Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, JapanAbstract:
Kawaji H +4 more
doaj
Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study. [PDF]
CureusBernan AP, Santos AGV.
europepmc +1 more source
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities [PDF]
, 2014 core +1 more source
The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism. [PDF]
Front Cardiovasc MedKurzmann-Guetl K +9 more
europepmc +1 more source
Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan. [PDF]
Drug Healthc Patient SafTakami A +4 more
europepmc +1 more source
Correction: Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study. [PDF]
CureusBernan AP, Santos AGV.
europepmc +1 more source